AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results
Published
AstraZeneca said Monday that its vaccine was found to be up to 90% effective at preventing COVID-19. But an error in that trial may warrant a new one.
Full Article